PORTLAND, Ore., Aug. 11, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today that a registration statement covering the resale of 3,253,333 shares of Znomics’ common stock was declared effective by the Securities and Exchange Commission.
